Global Astaxanthin 麻豆原创 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031The global Astaxanthin market size was valued at US$ 205 million in 2024 and is forecast to a readjusted size of USD 376 million by 2031 with a CAGR of 9.1% during review period. Global core astaxanthin manufacturers include Royal DSM N.V., Cyanotech Corporation, Fuji Chemical Industries Co., Ltd., BASF and BGG. The top five manufacturers account for approximately 68% of the global market share. From a production perspective, Europe is the largest anthocyanin production region in the world, accounting for nearly 56% of the market share. The second and third places are China and North America, accounting for 23% and 15% respectively. In terms of product type, natural astaxanthin is the largest market segment, accounting for more than 70% of the market. At the same time, in terms of application, feed is the largest application field, accounting for 55% of the market. This report is a detailed and comprehensive analysis for global Astaxanthin market. Both...Read more | USD 3,480.00 |
Global Intravenous Immunoglobulin (IVIg) 麻豆原创 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031The global Intravenous Immunoglobulin (IVIg) market size was valued at US$ 11890 million in 2024 and is forecast to a readjusted size of USD 17520 million by 2031 with a CAGR of 5.8% during review period. Intravenous Immunoglobulin, also called gamma globulin or antibodies, is a highly purified blood product preparation that is derived from large pools of plasma donors. Plasma from approximately 1,000 to 10,000 persons is present in each unit or 鈥渓ot鈥 of Intravenous Immunoglobulin. Global Intravenous Immunoglobulin (IVIg) main players are Baxter, Grifols, CSL, Octapharma, etc. Global top four manufacturers hold a share above 65%. North America is the largest market, with a share about 45%. This report is a detailed and comprehensive analysis for global Intravenous Immunoglobulin (IVIg) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this...Read more | USD 3,480.00 |
Global Bio Pharma Buffer 麻豆原创 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031The global Bio Pharma Buffer market size was valued at US$ 994 million in 2024 and is forecast to a readjusted size of USD 1591 million by 2031 with a CAGR of 7.0% during review period. A buffer solution is comprised of a weak conjugate acid-base pair, for example, a weak acid and its conjugate base, or a weak base and its conjugate acid. Small quantities of other acids or bases are neutralized when added to the solution, and as a result, the solution resists changes in pH. Solutions with stable pH are required for the processing of protein-based biologic APIs because of their sensitivity to changes in pH. The stable pH range and capacity (the amount of acid/base that can be added without a change in pH) of a buffer are determined by the conjugate acid-base pair. Most purification steps for downstream processing of biologics require buffers to equilibrate, condition, wash, elute, or concentrate the product. They are used in product isolation and purification steps to...Read more | USD 3,480.00 |
Global Medication Adherence Packaging Systems 麻豆原创 2025 by Company, Regions, Type and Application, Forecast to 2031The global Medication Adherence Packaging Systems market size was valued at US$ 897 million in 2024 and is forecast to a readjusted size of USD 1400 million by 2031 with a CAGR of 6.6% during review period. Medication adherence, or taking medications correctly, is generally defined as the extent to which patients take medication as prescribed by their doctors. This involves factors such as getting prescriptions filled, remembering to take medication on time, and understanding the directions. This report studies the Medication Adherence Packaging market. It can increase pharmacy efficiency in order to improve patients" adherence to their medication. Global Medication Adherence Packaging Systems key players include WestRock, Omnicell, Genoa Healthcare, Parata Systems (TCGRx), etc. Global top four manufacturers hold a share about 70%. North America is the largest market, with a share nearly 70%, followed by Europe, and Asia-Pacific, both have a share about...Read more | USD 3,480.00 |
Global Foot and Mouth Disease (FMD) Vaccines 麻豆原创 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031The global Foot and Mouth Disease (FMD) Vaccines market size was valued at US$ 1099 million in 2024 and is forecast to a readjusted size of USD 1937 million by 2031 with a CAGR of 8.5% during review period. Foot and Mouth Disease (FMD) vaccines are vaccines that provide active acquired immunity to Foot and Mouth Disease (FMD). Foot and Mouth Disease (FMD) is a highly contagious viral disease that primarily affects cloven-hooved livestock and wildlife like cattle, pigs, sheep and goats. Global key players of foot and mouth disease (FMD) vaccines include Jinyu Group, Cavet Bio, CAHIC, Shen Lian, Biogenesis Bag贸, etc. The top five players hold a share about 59%. China is the largest producer, has a share about 54%, followed by India and Europe, with share 8% and 4%, respectively. The largest market is Asia-Pacific, with a share about 74%, followed by South America and Europe, with share 16% and 4%, separately. This report is a detailed and comprehensive analysis for...Read more | USD 3,480.00 |